Consumer Alerts

Actos Bladder Cancer Lawsuits

Actos Linked to Bladder Cancer

Patients who took Actos, ActoPlus Met, ActoPlus Met XR, or Duetact and were diagnosed with bladder cancer may have legal recourse. According to a FDA safety announcement concerning Actos and bladder cancer, patients taking pioglitazone, an ingredient found in these diabetes drugs, for more than a year may have an increased risk of developing cancerous tumors of the bladder. It has been alleged that drug maker Takeda Pharmaceutical withheld information about the Actos bladder cancer risk and failed to provide adequate warnings with its diabetes drug. 

If you were diagnosed with bladder cancer after taking Actos, ActoPlus Met, ActoPlus Met XR, or Duetact, you may be entitled to financial compensation in light of these allegations. To find out if you are eligible, complete our free, no obligation case review form today.

Actos Bladder Cancer Link

On June 15, 2011, the FDA released a safety announcement concerning Actos and bladder cancer. The agency released the Actos bladder cancer warning following a review of data from a five-year analysis of an ongoing study of the drug by the manufacturer, Takeda Pharmaceuticals. While there was no overall increased risk of Actos bladder cancer among users, patients with the longest exposure to pioglitazone had a greater chance of developing the disease, according to the results. Specifically, the study revealed that patients taking the drug for more than a year had a 40% higher risk of developing Actos bladder cancer. 

In light of the link between Actos and bladder cancer, the FDA has advised that pioglitazone should not be prescribed to individuals who have bladder cancer, and should be used with caution in patients with a history of the disease. The agency also advised users to be on alert for signs which may possibly indicate Actos bladder cancer, such as:

• Blood in urine
• Back or lower abdominal pain 
• Urgent need to urinate
• Pain during urination  

Due to the possible Actos bladder cancer link, the agency also announced that the risk will be reflected in the drug's label and patient medication guide.

Actos Bladder Cancer Lawsuits

Potentially, Actos, ActoPlus Met, ActoPlus Met XR, or Duetact users who were diagnosed with bladder cancer may be able to take legal action if the manufacturer failed to properly warn doctors and patients about the possible Actos bladder cancer risk. If you have been diagnosed with bladder cancer after taking one of these drugs, fill out our no cost case review form today to contact our Actos bladder cancer lawyers to find out if you can file a claim seeking compensation for medical bills, pain and suffering and other damages. There is a time limit for filing Actos bladder cancer lawsuits, so do not hesitate to contact our Actos attorneys today by completing the form on the right.